Italy's Confindustria prepares strategy drive - medtech industry figure in new team
This article was originally published in Clinica
Italy’s pan-industrial confederation, Confindustria, which includes the medical technology association Assobiomedica, has unveiled a new policy strategy team tasked with drawing up a blueprint for “real industrial development” in Italy. The team is the brainchild of Confindustria’s newly-appointed president-designate, Giorgio Squinzi.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.